These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

584 related items for PubMed ID: 24906642

  • 1. Downregulation of miR-21 increases cisplatin sensitivity of non-small-cell lung cancer.
    Xu L, Huang Y, Chen D, He J, Zhu W, Zhang Y, Liu X.
    Cancer Genet; 2014 May; 207(5):214-20. PubMed ID: 24906642
    [Abstract] [Full Text] [Related]

  • 2. Downregulation of microRNA-196a enhances the sensitivity of non-small cell lung cancer cells to cisplatin treatment.
    Li Q, Yang Z, Chen M, Liu Y.
    Int J Mol Med; 2016 Apr; 37(4):1067-74. PubMed ID: 26936095
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line.
    Li JH, Luo N, Zhong MZ, Xiao ZQ, Wang JX, Yao XY, Peng Y, Cao J.
    Tumour Biol; 2016 Feb; 37(2):2387-94. PubMed ID: 26376998
    [Abstract] [Full Text] [Related]

  • 4. microRNA-381 suppresses the growth and increases cisplatin sensitivity in non-small cell lung cancer cells through inhibition of nuclear factor-κB signaling.
    Huang RS, Zheng YL, Zhao J, Chun X.
    Biomed Pharmacother; 2018 Feb; 98():538-544. PubMed ID: 29287202
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. miR-148b reverses cisplatin-resistance in non-small cell cancer cells via negatively regulating DNA (cytosine-5)-methyltransferase 1(DNMT1) expression.
    Sui C, Meng F, Li Y, Jiang Y.
    J Transl Med; 2015 Apr 28; 13():132. PubMed ID: 25927928
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Up-regulation of miR-146a increases the sensitivity of non-small cell lung cancer to DDP by downregulating cyclin J.
    Shi L, Xu Z, Wu G, Chen X, Huang Y, Wang Y, Jiang W, Ke B.
    BMC Cancer; 2017 Feb 15; 17(1):138. PubMed ID: 28202053
    [Abstract] [Full Text] [Related]

  • 13. MiR-219a-5p enhances cisplatin sensitivity of human non-small cell lung cancer by targeting FGF9.
    Rao C, Miao X, Zhao G, Zhang C, Shen H, Dong C, Yang M.
    Biomed Pharmacother; 2019 Jun 15; 114():108662. PubMed ID: 30999114
    [Abstract] [Full Text] [Related]

  • 14. Downregulation of miR-25 modulates non-small cell lung cancer cells by targeting CDC42.
    Yang T, Chen T, Li Y, Gao L, Zhang S, Wang T, Chen M.
    Tumour Biol; 2015 Mar 15; 36(3):1903-11. PubMed ID: 25432132
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.